Market Overview

Novo Nordisk A/S (NYSE: NVO)

57.25 +0.74 (1.31%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/18/19UBSDowngradesNeutral
11/18/19BarclaysUpgradesOverweight
9/17/19CitigroupUpgradesBuy
9/13/19Bank of AmericaReiteratesNeutral400.0
8/30/19JefferiesDowngradesUnderperform
6/20/19Deutsche BankDowngradesHold
6/11/19BarclaysUpgradesEqual-Weight
4/29/19Credit SuisseUpgradesOutperform
1/29/19Exane BNP ParibasInitiates Coverage OnOutperform
12/14/18Morgan StanleyInitiates Coverage OnEqual-Weight

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter